WEDNESDAY, June 12 (HealthDay News) — The big toe is not the biggest culprit in gout flare-ups, contrary to popular belief, a new study reports.
Researchers from the Mayo Clinic in Rochester, Minn., found that people with the highest risk of repeated cases of gout are those whose gout first appears in other joints, such [...]
RELATED CONDITIONS
Advertisement
WEEKLY NEWSLETTER
Free Healthy Living Email Newsletter
Get the latest health, fitness, anti-aging, and nutrition news, plus insights and updates from Health.com!
Will New Gout Findings Get a Toehold?
June 12, 2013
Painful Gout Afflicting More Americans: Study
July 28, 2011
THURSDAY, July 28 (HealthDay News) — Over the past two decades, the number of American adults with the painful joint disease gout has soared to 8.3 million, a new study finds.
The study’s authors blame the rise in gout — an inflammatory form of arthritis triggered by a buildup of uric acid in the joints — [...]
Women Who Drink Sugary Beverages Raise Risk of Gout
November 10, 2010
WEDNESDAY, Nov. 10 (HealthDay News) — Women who drink fructose-rich beverages such as sugar-sweetened sodas and orange juice are at increased risk for gout, a new study finds.
The incidence of gout — a painful type of inflammatory arthritis — in the United States increased from 16 per 100,000 people in 1977 to 42 per 100,000 [...]
Soda and OJ May Increase Risk of Gout
November 10, 2010
Drinking too much soda, orange juice, or other sugary drinks appears to increase the risk of developing gout, an especially painful form of arthritis, according to a new study in the Journal of the American Medical Association.
Krystexxa Approved for Gout
September 15, 2010
WEDNESDAY, Sept. 15 (HealthDay News) — Krystexxa (pegloticase) has been approved by the U.S. Food and Drug Administration for adults with gout who do not respond to, or who cannot tolerate, standard treatments.
Gout results when the body produces too much uric acid, which crystallizes in the joints or soft tissue. This leads to symptoms including [...]
Uloric Approved for Gout
February 18, 2009
Takeda Pharmaceuticals’ Uloric (febuxostat) has been approved by the U.S. Food and Drug Administration to treat gout, a painful condition characterized by elevated levels of uric acid that can build up in the blood, joints and soft tissue.
Three Genes Raise Gout Risk
October 1, 2008
TUESDAY, Sept. 30(HealthDay News) — Three genes may raise risks for painful gout by up to 40 times, researchers report.
The finding could help identify people at risk for the arthritic illness, long before symptoms start. One of the genes studied had already been associated with gout, but identifying all three genes could help develop new [...]
